EMERGING-CTONG 1103 Trial: Neoadjuvant Erlotinib in EGFR-Mutant Lung Cancer
Entrectinib Approved by FDA for ROS1-Positive NSCLC
Two-Drug Combination Targets Resistance in Cancer
Early Results With Dual Inhibition of VEGFR2 and PD-1 in Advanced Lung Cancer
IMpower130 Supports Atezolizumab Inclusion in Stage IV Lung Cancer Therapy
Is Biennial Lung Cancer Screening Safe and Effective?
How an Intervention Trial Addressed Racial Disparities in Treatment of Early-Stage Cancers
Does Stereotactic Body Radiotherapy Enhance the Effect of Immunotherapy for Lung Cancer?
Proceedings from the 15th Annual Winter Lung Cancer Conference
Advanced Non-Small Cell Lung Ccancer Patient Management Simulator
An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care-Lung Cancer: Advanced Disease
Fred and Pamela Buffett Cancer Center
Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance
University of Colorado Cancer Center
City of Hope Comprehensive Cancer Center
Dabrafenib + Trametinib
Lung Cancer Alliance
Lung Cancer Research Council, Inc.
The American Lung Association
Dusty Joy Foundation